Nanjing Pharmaceutical (600713.SH) issued 16.059 million restricted stocks for the first time to 173 incentive recipients.

Nanjing Pharmaceutical (600713.SH) announced that the company has approved the proposal "Regarding the Initial Grant of Restricted Stock to the Participants of the Company's 2025 Restricted Stock Incentive Plan." Due to the conditions for granting set out in the 2025 Restricted Stock Incentive Plan being achieved, the company has agreed to grant 16.059 million shares of restricted stock to 173 incentive recipients at a price of 2.46 yuan per share on May 9, 2025.